PT Siloam International Hospitals Tbk Reg-S

As of June 30, 2026, PT Siloam International Hospitals Tbk Reg-S carries a market capitalization of 28.70T, placing it among publicly traded companies globally. Its enterprise value stands at 30.18T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

PT Siloam International Hospitals Tbk Reg-S's next confirmed earnings release is scheduled for October 23, 2026.

As of June 30, 2026, PT Siloam International Hospitals Tbk Reg-S has 12.99B shares outstanding.

As of June 30, 2026, PT Siloam International Hospitals Tbk Reg-S trades at a trailing price-to-earnings ratio of 25.12. The price-to-sales ratio is 2.17, and the price-to-book ratio stands at 2.79.

As of June 30, 2026, PT Siloam International Hospitals Tbk Reg-S trades at an EV/EBITDA multiple of 10.85 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.28 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 17.61 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 30.18T versus a market cap of 28.70T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, PT Siloam International Hospitals Tbk Reg-S maintains a current ratio of 0.72, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.24, indicating elevated leverage, while an interest coverage ratio of 24.70 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, PT Siloam International Hospitals Tbk Reg-S posted a return on equity (ROE) of 11.96, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 10.89 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.83, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.79, useful for judging operating efficiency across full business cycles. The company generates approximately 895.01M in revenue per employee across its workforce of 14,808.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 39.89 indicates how many times PT Siloam International Hospitals Tbk Reg-S sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, PT Siloam International Hospitals Tbk Reg-S recorded 392.10B in income tax expense. That works out to an effective tax rate of 24.67, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.59T, leaving 1.14T in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, PT Siloam International Hospitals Tbk Reg-S's stock has declined approximately 2.12% over the past 52 weeks. The 50-day moving average sits at 2,051.30, while the 200-day moving average is 2,370.45.

Over the twelve months ended June 30, 2026, PT Siloam International Hospitals Tbk Reg-S generated 13.25T in revenue and converted that into 1.14T in net income, yielding earnings per share of 92.16. EBITDA reached 2.78T, while operating income came in at 1.76T.

As of June 30, 2026, PT Siloam International Hospitals Tbk Reg-S holds 1.24T in cash and equivalents against 2.45T in total debt, resulting in a net debt position of 854.21B. Total book value stands at 10.28T, with working capital of -1.39T providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, PT Siloam International Hospitals Tbk Reg-S posted a gross margin of 38.55, reflecting its pricing power and cost economics. The operating margin of 13.28 and net profit margin of 8.62 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield reaches 2.17, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to PT Siloam International Hospitals Tbk Reg-S shareholders.

PT Siloam International Hospitals Tbk Reg-S's most recent stock split took place on April 8, 2022 with a 1:8 split ratio.

As of June 30, 2026, PT Siloam International Hospitals Tbk Reg-S has an Altman Z-Score of 4.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.